4//SEC Filing
INOVIO PHARMACEUTICALS, INC. 4
Accession 0001055726-17-000003
$INOCIK 0001055726operating
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:43 PM ET
Size
8.5 KB
Accession
0001055726-17-000003
Insider Transaction Report
Form 4
Bagarazzi Mark
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2017-03-05+8,333→ 28,825 total - Exercise/Conversion
Restricted Stock Unit
2017-03-05−8,333→ 8,333 total→ Common Stock (8,333 underlying) - Tax Payment
Common Stock
2017-03-06$6.95/sh−3,067$21,316→ 25,758 total
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,000 restricted stock units is as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares will vest on March 5, 2018. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001055726
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:43 PM ET
- Size
- 8.5 KB